688393.SS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:00):

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China...

Stats
Dzisiejszy wolumen	817 216
Średni wolumen	1.78M
Kapitalizacja rynkowa	1.76B
EPS	CNY0.213 ( 2023-10-30 )
Następna data zysków	( CNY0 ) 2024-05-15
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	44.76
ATR14	CNY0.0190 (0.10%)

Wolumen Korelacja

Długi: -0.06 (neutral)

Krótki: -0.41 (neutral)

Signal:(42.08) Neutral

Guangzhou LBP Medicine Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Guangzhou LBP Medicine Korelacja - Waluta/Towar

-0.13
( neutral )

-0.25
( neutral )

0.00
( neutral )

0.06
( neutral )

0.20
( neutral )

Guangzhou LBP Medicine Finanse

Annual	2023
Przychody:	CNY497.29M
Zysk brutto:	CNY473.93M (95.30 %)
EPS:	CNY0.430

FY	2023
Przychody:	CNY497.29M
Zysk brutto:	CNY473.93M (95.30 %)
EPS:	CNY0.430

FY	2022
Przychody:	CNY507.38M
Zysk brutto:	CNY360.63M (71.08 %)
EPS:	CNY0.310

FY	2021
Przychody:	CNY438.99M
Zysk brutto:	CNY342.04M (77.92 %)
EPS:	CNY0.850

Financial Reports:

No articles found.

Guangzhou LBP Medicine

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China. It offers pathological diagnostic reagents and ancillary equipment, including liquid-based cytology, such as gynecological series, non-gynecological series, and equipment; fluorescence in situ hybridization products for various applications in breast, bladder, lung, cervical, prostate, and thyroid cancer; and neuroblastoma, soft tissue sarcoma, other solid tumors, prenatal screening and abortion, oligodendrocytes tumor, lymphoma, multiple myeloma, chronic myelogenous and lymphocytic leukemia, myelodysplastic syndromes, acute myeloid leukemia, and acute lymphoblastic leukemia. The company also provides immunohistochemistry products, which comprise antibodies, detection systems, repair systems, complementary products, and immunohistochemistry kit, as well as molecular genetic diagnosis products. Guangzhou LBP Medicine Science & Technology Co., Ltd. was founded in 2005 and is based in Guangzhou, China.